Arcutis Biotherapeutics (NASDAQ:ARQT) Trading Up 7.1% on Analyst Upgrade
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Get Free Report)’s share price rose 7.1% during trading on Tuesday after Jefferies Financial Group raised their price target on the stock from $16.00 to $19.00. Jefferies Financial Group currently has a buy rating on the stock. Arcutis Biotherapeutics traded as high as $15.25 and last traded at $15.40. Approximately […]
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Get Free Report)’s share price rose 7.1% during trading on Tuesday after Jefferies Financial Group raised their price target on the stock from $16.00 to $19.00. Jefferies Financial Group currently has a buy rating on the stock. Arcutis Biotherapeutics traded as high as $15.25 and last traded at $15.40. Approximately […]
